These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1293647

  • 21. Biological monitoring for occupational exposures to ortho-toluidine and aniline.
    Stettler LE, Savage RE, Brown KK, Cheever KL, Weigel WW, DeBord DG, Teass AW, Dankovic D, Ward EM.
    Scand J Work Environ Health; 1992; 18 Suppl 2():78-81. PubMed ID: 1514095
    [No Abstract] [Full Text] [Related]

  • 22. NIOSH alert: request for assistance in preventing bladder cancer from exposure to o-toluidine and aniline.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1991 May 31; 40(21):353-4. PubMed ID: 2034200
    [No Abstract] [Full Text] [Related]

  • 23. Distinct differences in the mechanisms of mucosal damage and γ-H2AX formation in the rat urinary bladder treated with o-toluidine and o-anisidine.
    Toyoda T, Matsushita K, Morikawa T, Yamada T, Miyoshi N, Ogawa K.
    Arch Toxicol; 2019 Mar 31; 93(3):753-762. PubMed ID: 30656379
    [Abstract] [Full Text] [Related]

  • 24. Preventing bladder cancer from exposure to o-toluidine and aniline.
    Am Ind Hyg Assoc J; 1991 May 31; 52(5):A260, A262. PubMed ID: 1951057
    [No Abstract] [Full Text] [Related]

  • 25. o-Toluidine and o-toluidine hydrochloride.
    Rep Carcinog; 2004 May 31; 11():III258-9. PubMed ID: 21089974
    [No Abstract] [Full Text] [Related]

  • 26. Acetoaceto-o-Toluidide Enhances Cellular Proliferative Activity in the Urinary Bladder of Rats.
    Okuno T, Gi M, Fujioka M, Yukimatu N, Kakehashi A, Takeuchi A, Endo G, Endo Y, Wanibuchi H.
    Toxicol Sci; 2019 Jun 01; 169(2):456-464. PubMed ID: 30796441
    [Abstract] [Full Text] [Related]

  • 27. The aromatic amine carcinogens o-toluidine and o-anisidine induce free radicals and intrachromosomal recombination in Saccharomyces cerevisiae.
    Brennan RJ, Schiestl RH.
    Mutat Res; 1999 Nov 29; 430(1):37-45. PubMed ID: 10592316
    [Abstract] [Full Text] [Related]

  • 28. Carcinogenicity of some aromatic amines, organic dyes, and related exposures.
    Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group.
    Lancet Oncol; 2008 Apr 29; 9(4):322-3. PubMed ID: 18405853
    [No Abstract] [Full Text] [Related]

  • 29. 4-Chloro-ortho-toluidine.
    IARC Monogr Eval Carcinog Risks Hum; 2000 Apr 29; 77():323-39. PubMed ID: 11100405
    [No Abstract] [Full Text] [Related]

  • 30. ortho-toluidine.
    IARC Monogr Eval Carcinog Risks Hum; 2000 Apr 29; 77():267-322. PubMed ID: 11100404
    [No Abstract] [Full Text] [Related]

  • 31. Comparative carcinogenicity of o-toluidine hydrochloride and o-nitrosotoluene in F-344 rats.
    Hecht SS, El-Bayoumy K, Rivenson A, Fiala E.
    Cancer Lett; 1982 Apr 29; 16(1):103-8. PubMed ID: 7116337
    [Abstract] [Full Text] [Related]

  • 32. DNA adducts of ortho-toluidine in human bladder.
    Böhm F, Schmid D, Denzinger S, Wieland WF, Richter E.
    Biomarkers; 2011 Mar 29; 16(2):120-8. PubMed ID: 21117897
    [Abstract] [Full Text] [Related]

  • 33. Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform.
    Popp W, Schmieding W, Speck M, Vahrenholz C, Norpoth K.
    Br J Ind Med; 1992 Aug 29; 49(8):529-31. PubMed ID: 1515344
    [Abstract] [Full Text] [Related]

  • 34. ortho-Toluidine and ortho-toluidine hydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr 29; 27():155-75. PubMed ID: 6955262
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Risk assessment for o-toluidine and bladder cancer incidence.
    Park RM, Carreón T, Hanley KW.
    Am J Ind Med; 2021 Sep 29; 64(9):758-770. PubMed ID: 34114240
    [Abstract] [Full Text] [Related]

  • 38. Biological monitoring for occupational exposures to o-toluidine and aniline.
    Teass AW, DeBord DG, Brown KK, Cheever KL, Stettler LE, Savage RE, Weigel WW, Dankovic D, Ward E.
    Int Arch Occup Environ Health; 1993 Sep 29; 65(1 Suppl):S115-8. PubMed ID: 8406905
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A re-examination of the cause of excess bladder cancers in chemical plant workers.
    Freudenthal RI, Anderson DP.
    J Natl Cancer Inst; 1994 Jan 05; 86(1):59-62. PubMed ID: 8271286
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.